(AROC) Archrock - Overview
Sector: EnergyIndustry: Oil & Gas Equipment & Services | Exchange NYSE (USA) | Currency USD | Market Cap: 6.369m | Total Return 39.9% in 12m
Stock: Compression Equipment, Parts, Maintenance, Packaging
Total Rating 65
Risk 31
Buy Signal -0.03
| Risk 5d forecast | |
|---|---|
| Volatility | 33.9% |
| Relative Tail Risk | 0.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.01 |
| Alpha | 22.80 |
| Character TTM | |
|---|---|
| Beta | 1.076 |
| Beta Downside | 2.161 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.31% |
| CAGR/Max DD | 2.07 |
EPS (Earnings per Share)
Revenue
Description: AROC Archrock March 05, 2026
Archrock, Inc. (AROC) is a US-based energy infrastructure company specializing in natural gas compression. Its operations are divided into Contract Operations and Aftermarket Services.
The Contract Operations segment involves Archrock designing, owning, and maintaining natural gas compression equipment. This equipment is crucial for moving natural gas from production sites to processing plants and ultimately to market, addressing the energy sectors need for efficient gas transportation.
Aftermarket Services include selling parts and components, as well as providing maintenance, overhaul, and reconfiguration services for customer-owned compression equipment. This segment supports the longevity and performance of existing infrastructure, a common service model within the industrial equipment sector.
Archrock also packages natural gas compressors for sale or contract compression. The company serves various clients in the oil and natural gas industry, including processors, gatherers, and transporters. For more detailed analysis, consider exploring its financial performance on ValueRay.
Headlines to watch out for
- Natural gas production growth drives compression service demand
- Energy commodity prices impact customer investment decisions
- Regulatory changes affect pipeline and infrastructure development
- Maintenance and overhaul services provide recurring revenue
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 322.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.91 > 1.0 |
| NWC/Revenue: 7.18% < 20% (prev 3.85%; Δ 3.34% < -1%) |
| CFO/TA 0.14 > 3% & CFO 622.1m > Net Income 322.3m |
| Net Debt (2.42b) to EBITDA (854.3m): 2.83 < 3 |
| Current Ratio: 1.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (174.5m) vs 12m ago 0.35% < -2% |
| Gross Margin: 61.18% > 18% (prev 0.60%; Δ 6.06k% > 0.5%) |
| Asset Turnover: 36.45% > 50% (prev 30.27%; Δ 6.18% > 0%) |
| Interest Coverage Ratio: 3.61 > 6 (EBITDA TTM 854.3m / Interest Expense TTM 165.3m) |
Altman Z'' -1.38
| A: 0.02 (Total Current Assets 304.2m - Total Current Liabilities 197.1m) / Total Assets 4.35b |
| B: -0.52 (Retained Earnings -2.26b / Total Assets 4.35b) |
| C: 0.15 (EBIT TTM 596.4m / Avg Total Assets 4.09b) |
| D: -0.79 (Book Value of Equity -2.26b / Total Liabilities 2.86b) |
| Altman-Z'' Score: -1.38 = CCC |
Beneish M -2.66
| DSRI: 1.08 (Receivables 183.8m/132.5m, Revenue 1.49b/1.16b) |
| GMI: 0.99 (GM 61.18% / 60.39%) |
| AQI: 1.30 (AQ_t 0.09 / AQ_t-1 0.07) |
| SGI: 1.29 (Revenue 1.49b / 1.16b) |
| TATA: -0.07 (NI 322.3m - CFO 622.1m) / TA 4.35b) |
| Beneish M-Score: -2.66 (Cap -4..+1) = A |
What is the price of AROC shares?
As of March 26, 2026, the stock is trading at USD 36.86 with a total of 1,581,600 shares traded.
Over the past week, the price has changed by +3.13%, over one month by +5.22%, over three months by +44.35% and over the past year by +39.86%.
Over the past week, the price has changed by +3.13%, over one month by +5.22%, over three months by +44.35% and over the past year by +39.86%.
Is AROC a buy, sell or hold?
Archrock has received a consensus analysts rating of 4.57.
Therefore, it is recommended to buy AROC.
- StrongBuy: 4
- Buy: 3
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AROC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 38.4 | 4.3% |
| Analysts Target Price | 38.4 | 4.3% |
AROC Fundamental Data Overview March 21, 2026
P/E Trailing = 19.847
P/E Forward = 19.1571
P/S = 4.2753
P/B = 4.2602
P/EG = 1.5972
Revenue TTM = 1.49b USD
EBIT TTM = 596.4m USD
EBITDA TTM = 854.3m USD
Long Term Debt = 2.41b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.42b USD (from netDebt column, last quarter)
Enterprise Value = 8.79b USD (6.37b + Debt 2.42b - CCE 1.55m)
Interest Coverage Ratio = 3.61 (Ebit TTM 596.4m / Interest Expense TTM 165.3m)
EV/FCF = 73.46x (Enterprise Value 8.79b / FCF TTM 119.6m)
FCF Yield = 1.36% (FCF TTM 119.6m / Enterprise Value 8.79b)
FCF Margin = 8.03% (FCF TTM 119.6m / Revenue TTM 1.49b)
Net Margin = 21.63% (Net Income TTM 322.3m / Revenue TTM 1.49b)
Gross Margin = 61.18% ((Revenue TTM 1.49b - Cost of Revenue TTM 578.3m) / Revenue TTM)
Gross Margin QoQ = 52.96% (prev 66.05%)
Tobins Q-Ratio = 2.02 (Enterprise Value 8.79b / Total Assets 4.35b)
Interest Expense / Debt = 1.74% (Interest Expense 42.2m / Debt 2.42b)
Taxrate = 21.43% (31.9m / 148.6m)
NOPAT = 468.6m (EBIT 596.4m * (1 - 21.43%))
Current Ratio = 1.54 (Total Current Assets 304.2m / Total Current Liabilities 197.1m)
Debt / Equity = 1.62 (Debt 2.42b / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = 2.83 (Net Debt 2.42b / EBITDA 854.3m)
Debt / FCF = 20.22 (Net Debt 2.42b / FCF TTM 119.6m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.89% (Net Income 322.3m / Total Assets 4.35b)
RoE = 22.73% (Net Income TTM 322.3m / Total Stockholder Equity 1.42b)
RoCE = 15.58% (EBIT 596.4m / Capital Employed (Equity 1.42b + L.T.Debt 2.41b))
RoIC = 12.05% (NOPAT 468.6m / Invested Capital 3.89b)
WACC = 7.46% (E(6.37b)/V(8.79b) * Re(9.77%) + D(2.42b)/V(8.79b) * Rd(1.74%) * (1-Tc(0.21)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.37%
[DCF] Terminal Value 73.27% ; FCFF base≈100.0m ; Y1≈65.7m ; Y5≈30.0m
[DCF] Fair Price = N/A (negative equity: EV 661.1m - Net Debt 2.42b = -1.76b; debt exceeds intrinsic value)
EPS Correlation: 86.23 | EPS CAGR: 209.3% | SUE: 4.0 | # QB: 1
Revenue Correlation: 98.38 | Revenue CAGR: 18.87% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=+0.024 | Chg30d=+0.024 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=2.07 | Chg7d=+0.091 | Chg30d=+0.091 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+4.7%
EPS next Year (2027-12-31): EPS=2.34 | Chg7d=-0.003 | Chg30d=-0.003 | Revisions Net=+2 | Growth EPS=+12.7% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 9.8% - Earnings Yield 5.0%)
[Growth] Growth Spread = -2.5% (Analyst 2.2% - Implied 4.7%)
P/E Forward = 19.1571
P/S = 4.2753
P/B = 4.2602
P/EG = 1.5972
Revenue TTM = 1.49b USD
EBIT TTM = 596.4m USD
EBITDA TTM = 854.3m USD
Long Term Debt = 2.41b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 2.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.42b USD (from netDebt column, last quarter)
Enterprise Value = 8.79b USD (6.37b + Debt 2.42b - CCE 1.55m)
Interest Coverage Ratio = 3.61 (Ebit TTM 596.4m / Interest Expense TTM 165.3m)
EV/FCF = 73.46x (Enterprise Value 8.79b / FCF TTM 119.6m)
FCF Yield = 1.36% (FCF TTM 119.6m / Enterprise Value 8.79b)
FCF Margin = 8.03% (FCF TTM 119.6m / Revenue TTM 1.49b)
Net Margin = 21.63% (Net Income TTM 322.3m / Revenue TTM 1.49b)
Gross Margin = 61.18% ((Revenue TTM 1.49b - Cost of Revenue TTM 578.3m) / Revenue TTM)
Gross Margin QoQ = 52.96% (prev 66.05%)
Tobins Q-Ratio = 2.02 (Enterprise Value 8.79b / Total Assets 4.35b)
Interest Expense / Debt = 1.74% (Interest Expense 42.2m / Debt 2.42b)
Taxrate = 21.43% (31.9m / 148.6m)
NOPAT = 468.6m (EBIT 596.4m * (1 - 21.43%))
Current Ratio = 1.54 (Total Current Assets 304.2m / Total Current Liabilities 197.1m)
Debt / Equity = 1.62 (Debt 2.42b / totalStockholderEquity, last quarter 1.49b)
Debt / EBITDA = 2.83 (Net Debt 2.42b / EBITDA 854.3m)
Debt / FCF = 20.22 (Net Debt 2.42b / FCF TTM 119.6m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.89% (Net Income 322.3m / Total Assets 4.35b)
RoE = 22.73% (Net Income TTM 322.3m / Total Stockholder Equity 1.42b)
RoCE = 15.58% (EBIT 596.4m / Capital Employed (Equity 1.42b + L.T.Debt 2.41b))
RoIC = 12.05% (NOPAT 468.6m / Invested Capital 3.89b)
WACC = 7.46% (E(6.37b)/V(8.79b) * Re(9.77%) + D(2.42b)/V(8.79b) * Rd(1.74%) * (1-Tc(0.21)))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.37%
[DCF] Terminal Value 73.27% ; FCFF base≈100.0m ; Y1≈65.7m ; Y5≈30.0m
[DCF] Fair Price = N/A (negative equity: EV 661.1m - Net Debt 2.42b = -1.76b; debt exceeds intrinsic value)
EPS Correlation: 86.23 | EPS CAGR: 209.3% | SUE: 4.0 | # QB: 1
Revenue Correlation: 98.38 | Revenue CAGR: 18.87% | SUE: -0.15 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.48 | Chg7d=+0.024 | Chg30d=+0.024 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=2.07 | Chg7d=+0.091 | Chg30d=+0.091 | Revisions Net=+2 | Growth EPS=+9.1% | Growth Revenue=+4.7%
EPS next Year (2027-12-31): EPS=2.34 | Chg7d=-0.003 | Chg30d=-0.003 | Revisions Net=+2 | Growth EPS=+12.7% | Growth Revenue=+5.9%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 9.8% - Earnings Yield 5.0%)
[Growth] Growth Spread = -2.5% (Analyst 2.2% - Implied 4.7%)